Answers are grounded in this paper and cite their sources.
Objective The ketogenic diet treatment (KDT) is an established non‐pharmacological treatment for drug‐resistant epilepsy (DRE). However, rigorous research for seizure efficacy based on randomized controlled studies in adolescents and adults remains limited, and cognitive outcomes are rarely assessed using standardized measures. Methods This scoping review has mapped evidence on cognitive outcomes of KDT in adolescents and adults with epilepsy. Following PRISMA‐ScR guidelines, PubMed and Embase were searched for studies published between 1986 and 2026. Eligibility for this review required inclusion of adolescents or adults with epilepsy receiving KDT and reporting cognitive outcomes. Results Of 951 records, 19 studies were included. Overall, KDT was associated with favorable seizure and cognitive outcomes, although reports of cognitive outcomes were generally subjective. Significance Rigorous research designs were scarce, and evidence remains limited; future studies should use stronger designs, larger samples, standardized cognitive assessments, and longer follow‐up periods. Plain Language Summary Research shows that people with epilepsy often experience difficulties with the brain's ability to process information. While dietary treatments have been shown to be effective for seizure control, less is known about their effects on cognition. We reviewed published research examining cognitive outcomes in adolescents and adults with epilepsy following dietary treatment. Most studies suggested that these diets had a positive effect on aspects of cognitive functioning. However, the available evidence remains limited. More studies with better designs using well‐established cognitive assessments are needed to better understand these effects.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: